---
figid: PMC10616517__bt-31-6-599-f6
figtitle: Novel ferroptosis-targeted therapeutic strategy by combination of melatonin
  and zileuton
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10616517
filename: PMC10616517__bt-31-6-599-f6.jpg
figlink: /pmc/articles/PMC10616517/figure/F6
number: F6
caption: Schematic diagram of the novel ferroptosis-targeted therapeutic strategy
  by combination of melatonin and zileuton. The scheme shows that the combination
  of melatonin and zileuton increases cell survival by inhibiting the ferroptosis
  signaling pathway in renal injury
papertitle: Synergistic Renoprotective Effect of Melatonin and Zileuton by Inhibition
  of Ferroptosis via the AKT/mTOR/NRF2 Signaling in Kidney Injury and Fibrosis
reftext: Kyung Hee Jung, et al. Biomol Ther (Seoul). 2023 Nov 1;31(6).
year: '2023'
doi: 10.4062/biomolther.2023.062
journal_title: Biomolecules & Therapeutics
journal_nlm_ta: Biomol Ther (Seoul)
publisher_name: The Korean Society of Applied Pharmacology
keywords: Ferroptosis | RSL3 | Kidney injury | Fibrosis | GPX4
automl_pathway: 0.9357922
figid_alias: PMC10616517__F6
figtype: Figure
redirect_from: /figures/PMC10616517__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10616517__bt-31-6-599-f6.html
  '@type': Dataset
  description: Schematic diagram of the novel ferroptosis-targeted therapeutic strategy
    by combination of melatonin and zileuton. The scheme shows that the combination
    of melatonin and zileuton increases cell survival by inhibiting the ferroptosis
    signaling pathway in renal injury
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HMOX1
  - ALOX5
  - AKT1
  - AKT2
  - AKT3
  - GABPA
  - NFE2L2
  - GPX4
  - Fe3+
  - Fe2+
  - Cysteine
  - Melatonin
  - Zileuton
  - GSH
  - Nucleus
  - Lipid
---
